Helge Waal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Helge Waal has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Clausen
Norwegian Centre for Addiction Research (SERAF), Institute of Clinical Medicine, University of Oslo, Norway
6 shared publications Jørg Mørland
4 shared publications- Ivar Skeie
Centre for Addiction Treatment, Oslo University Hospital, Oslo, Norway
2 shared publications Jørg G. Mørland
2 shared publications- Linda Elise Wüsthoff
Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
2 shared publications - Mette Brekke
Department of General Practice, Institute of Health and Society, University of Oslo
2 shared publications
Latest Publications
- 10 January 2022
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 142 (1)
Oksykodon mot rastløse bein?
- 10 January 2022
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 142 (1)
Oksykodon mot rastløse bein?
- 28 September 2020
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 140 (13)
H. Waal og medarbeidere svarer
28.09.2020: Kommentar - Vi er godt kjent med den studien av kvetiapinforskrivning Gjerden og Slørdal refererer til.
- 28 September 2020
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 140 (13)
H. Waal og medarbeidere svarer
28.09.2020: Kommentar - Vi er godt kjent med den studien av kvetiapinforskrivning Gjerden og Slørdal refererer til.
- 25 August 2020
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 140 (12)
Quetiapine abuse – myth or reality?
25.08.2020: Kronikk - Kvetiapin blir i økende grad brukt som beroligende og søvngivende middel, særlig innen behandling av ruslidelser.
- 25 August 2020
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 140 (12)
Quetiapine abuse – myth or reality?
25.08.2020: Kronikk - Kvetiapin blir i økende grad brukt som beroligende og søvngivende middel, særlig innen behandling av ruslidelser.
- Open Access
- 2 July 2019
- Published by Springer Nature in BMC Health Services Research
- Vol. 19 (1) , 1-10
Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
Mortality rates and causes of death among individuals in opioid agonist treatment (OAT) vary according to several factors such as geographical region, age, gender, subpopulations, drug culture and OAT status. Patients in OAT are ageing due to effective OAT as well as demographic changes, which has implications for morbidity and mortality. Norway has one of the oldest OAT populations in Europe. Because of the varying mortality rates and causes of death in different subgroups and countries, research gaps still exist. The aims of this study were to describe the causes of death among OAT patients in Norway, to estimate all-cause and cause-specific crude mortality rates (CMRs) during OAT and to explore characteristics associated with drug-induced cause of death compared with other causes of death during OAT. This was a national, observational register study. Data from the Norwegian Cause of Death Registry and the Norwegian Patient Registry were combined with data from medical records. We included all patients in the Norwegian OAT programme who died not more than 5 days after the last intake of OAT medication, between 1 January 2014 and 31 December 2015. In the 2-year observation period, 200 (1.4%) of the OAT patients died. A forensic or medical autopsy was performed in 63% of the cases. The mean age at the time of death was 48.9 years (standard deviation 8.4), and 74% were men. Somatic disease was the most common cause of death (45%), followed by drug-induced death (42%), and violent death (12%). In general, CMRs increased with age, and they were higher in men and in patients taking methadone compared with buprenorphine. Increasing somatic comorbidity, measured by the Charlson comorbidity index, reduced the odds of dying of a drug-induced cause of death compared with other causes of death. Both somatic and drug-induced causes of death were common during OAT. Improved treatment and follow-up of chronic diseases, especially in patients aged > 40 years, and continuous measures to reduce drug-induced deaths appear to be essential to reduce future morbidity and mortality burdens in this population.
- 2 July 2019
- Published by Springer Nature in BMC Health Services Research
- Vol. 19 (1) , 1-10
Open AccessMortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
Mortality rates and causes of death among individuals in opioid agonist treatment (OAT) vary according to several factors such as geographical region, age, gender, subpopulations, drug culture and OAT status. Patients in OAT are ageing due to effective OAT as well as demographic changes, which has implications for morbidity and mortality. Norway has one of the oldest OAT populations in Europe. Because of the varying mortality rates and causes of death in different subgroups and countries, research gaps still exist. The aims of this study were to describe the causes of death among OAT patients in Norway, to estimate all-cause and cause-specific crude mortality rates (CMRs) during OAT and to explore characteristics associated with drug-induced cause of death compared with other causes of death during OAT. This was a national, observational register study. Data from the Norwegian Cause of Death Registry and the Norwegian Patient Registry were combined with data from medical records. We included all patients in the Norwegian OAT programme who died not more than 5 days after the last intake of OAT medication, between 1 January 2014 and 31 December 2015. In the 2-year observation period, 200 (1.4%) of the OAT patients died. A forensic or medical autopsy was performed in 63% of the cases. The mean age at the time of death was 48.9 years (standard deviation 8.4), and 74% were men. Somatic disease was the most common cause of death (45%), followed by drug-induced death (42%), and violent death (12%). In general, CMRs increased with age, and they were higher in men and in patients taking methadone compared with buprenorphine. Increasing somatic comorbidity, measured by the Charlson comorbidity index, reduced the odds of dying of a drug-induced cause of death compared with other causes of death. Both somatic and drug-induced causes of death were common during OAT. Improved treatment and follow-up of chronic diseases, especially in patients aged > 40 years, and continuous measures to reduce drug-induced deaths appear to be essential to reduce future morbidity and mortality burdens in this population.
- Open Access
- 6 May 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (8)
H. Waal og J. Mørland svarer
06.05.2019: Kommentar - Det er ikke helt klart for oss hva Andreas Blomkvist og Sverre Eika mener vi skal beklage.
- 6 May 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (8)
Open AccessH. Waal og J. Mørland svarer
06.05.2019: Kommentar - Det er ikke helt klart for oss hva Andreas Blomkvist og Sverre Eika mener vi skal beklage.
- Open Access
- 11 February 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (3)
'The entire pharmaceutical compendium' in the treatment of substance use disorders
11.02.2019: Kronikk - I Norge har forskrivningen av vanedannende medisiner vært restriktiv.
- 11 February 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (3)
Open Access'The entire pharmaceutical compendium' in the treatment of substance use disorders
11.02.2019: Kronikk - I Norge har forskrivningen av vanedannende medisiner vært restriktiv.
- Open Access
- 1 January 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (6)
H. Waal & J. Mørland svarer
25.03.2019: Kommentar - Arne Vaaler finner ikke at vi «bringer nøktern, oppdatert informasjon til de behandlerne som møter mennesker i akutte livskriser og utvalgte pasienter med kroniske angstplager eller depressive tilstander».
- 1 January 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (6)
Open AccessH. Waal & J. Mørland svarer
25.03.2019: Kommentar - Arne Vaaler finner ikke at vi «bringer nøktern, oppdatert informasjon til de behandlerne som møter mennesker i akutte livskriser og utvalgte pasienter med kroniske angstplager eller depressive tilstander».
- Open Access
- 26 June 2017
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 137 (12/13) , 857
H. Waal & J. Mørland svarer:
Kommentar - tilsvar - Ketil Slagstad bommer i sitt tilsvar (1) til vår artikkel "Stoff, straff og sosial smitte – en uheldig sammenblanding" i Tidsskriftet nr.
- 26 June 2017
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 137 (12/13) , 857
Open AccessH. Waal & J. Mørland svarer:
Kommentar - tilsvar - Ketil Slagstad bommer i sitt tilsvar (1) til vår artikkel "Stoff, straff og sosial smitte – en uheldig sammenblanding" i Tidsskriftet nr.
- Open Access
- 16 February 2017
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 137 (4) , 262
Stoff, straff og sosial smitte – en uheldig sammenblanding
Kommentar og debatt - «Dagens narkotikapolitikk er basert på et sviktende vitenskapelig grunnlag og bør revurderes», skriver redaktør Ketil Slagstad på lederplass i Tidsskriftet.
- 16 February 2017
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 137 (4) , 262
Open AccessStoff, straff og sosial smitte – en uheldig sammenblanding
Kommentar og debatt - «Dagens narkotikapolitikk er basert på et sviktende vitenskapelig grunnlag og bør revurderes», skriver redaktør Ketil Slagstad på lederplass i Tidsskriftet.
- Open Access
- 1 February 2017
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 34 (1) , 72-79
Den aldrende LAR pasienten
Background: Opioid maintenance treatment (OMT) secures a low mortality in a vulnerable population and is often a lifelong treatment. One would therefore expect an increasing prevalence of OMT among the elderly. This article describes a study with three elements; a literature review, an investigation of occurrence and an exploration of elderly patients’ needs and experiences. Material and methods: PsycINFO, Ovid Medline and Embase were searched with reference words for opioid maintenance and age. Norway has a national cohort study of patients in OMT describing recruitment, retention in treatment, age and mortality. A prognosis of numbers in treatment older than 50 and 60 years were extrapolated based on probabilistic premises. Finally, a qualitative interview study of OMT patients in two municipalities near Oslo was performed. Five OMT patients aged between 58 and 64 years were interviewed with open questions on thoughts, needs and experiences. Findings: The review points to an increasing population with psychiatric and somatic comorbidities and diverse needs. Their opinions and experiences seem largely unexplored. The population estimates indicate that Norway by 2018 will have between 3084 and 3567 individuals older than 50 years and between 201 and 302 individuals older than 60 years in OMT. The qualitative study demonstrated that the elderly OMT patient typically attributes their being alive to OMT. It is a life with a high prevalence of ailments and diseases. Their somatic diseases are mostly adequately treated by their GP, but they feel left alone with a high level of mental problems and loneliness. They miss follow-up from the OMT and social services and are not met on existential thoughts and sorrow for their life. A wish to end OMT during their lifetime is noteworthy. This would necessitate a close collaboration with the OMT services and support from a social network. Conclusions: The study points to insufficient knowledge of and strategies to meet an increasing number of individuals with composite problems in OMT. The numbers will remain too small to warrant specially designed local projects, but large enough to necessitate awareness and competencies in the ordinary municipal health and social services.
- 1 February 2017
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 34 (1) , 72-79
Open AccessDen aldrende LAR pasienten
Background: Opioid maintenance treatment (OMT) secures a low mortality in a vulnerable population and is often a lifelong treatment. One would therefore expect an increasing prevalence of OMT among the elderly. This article describes a study with three elements; a literature review, an investigation of occurrence and an exploration of elderly patients’ needs and experiences. Material and methods: PsycINFO, Ovid Medline and Embase were searched with reference words for opioid maintenance and age. Norway has a national cohort study of patients in OMT describing recruitment, retention in treatment, age and mortality. A prognosis of numbers in treatment older than 50 and 60 years were extrapolated based on probabilistic premises. Finally, a qualitative interview study of OMT patients in two municipalities near Oslo was performed. Five OMT patients aged between 58 and 64 years were interviewed with open questions on thoughts, needs and experiences. Findings: The review points to an increasing population with psychiatric and somatic comorbidities and diverse needs. Their opinions and experiences seem largely unexplored. The population estimates indicate that Norway by 2018 will have between 3084 and 3567 individuals older than 50 years and between 201 and 302 individuals older than 60 years in OMT. The qualitative study demonstrated that the elderly OMT patient typically attributes their being alive to OMT. It is a life with a high prevalence of ailments and diseases. Their somatic diseases are mostly adequately treated by their GP, but they feel left alone with a high level of mental problems and loneliness. They miss follow-up from the OMT and social services and are not met on existential thoughts and sorrow for their life. A wish to end OMT during their lifetime is noteworthy. This would necessitate a close collaboration with the OMT services and support from a social network. Conclusions: The study points to insufficient knowledge of and strategies to meet an increasing number of individuals with composite problems in OMT. The numbers will remain too small to warrant specially designed local projects, but large enough to necessitate awareness and competencies in the ordinary municipal health and social services.